Skip to main content
. 2020 Nov 2;11:551780. doi: 10.3389/fgene.2020.551780

Table 2.

Quality assessment of each article included in the systematic review.

References Study design Selection Comparability Outcome Total stars
Representati-veness of the sample Sample size justification Exclusion of other relevant diseases Ascertainment of exposure (C9orf72) Control for confounding factors Assessment of outcome (HLD diagnosis) Statistical test
Hensman Moss et al. (2014a) Cross-sectional + ++ ++ + 6/10
Kostic et al. (2014) Cross-sectional + + ++ ++ + 7/10
Koutsis et al. (2015) Cross-sectional + + ++ ++ + 7/10
Mariani et al. (2016) Cross-sectional + + ++ ++ + 7/10
Martins et al. (2018a) Cross-sectional + + ++ ++ + 7/10
Baine et al. (2018) Cross-sectional + + ++ ++ + 7/10
Ida et al. (2018) Cross-sectional + + ++ ++ + 7/10
Kaur et al. (2020) Cross-sectional + ++ + 4/10
References Study design Selection Comparability Exposure Total stars
Case definition (HLD diagnosis) Representativeness of the cases to target population Selection of community-based controls Definition of controls Control for confounding factors Ascertainment of exposure (C9orf72) Same method used for cases and controls All cases and controls were assessed for exposure
Rikos et al. (2020) Case-control + + + + + + + 7/9
Fedotova et al. (2016) Case-control + + + + + + 6/9

HLD, Huntington-Like Disorder.